S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/RA Capital Management/Q1 2021

RA Capital Management

Periodo: Q1 2021 Β· Depositato: 2021-05-17
Vedi su SEC EDGAR β†—
AUM
$6.63B
Valore totale del portafoglio
Posizioni
82
Titoli dichiarati
Prima Posizione
ASND
12.5% $826.4M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-05-17) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
ASNDASCENDIS PHARMA A/S$826.4M12.46%$128.88$274.50+113.0%
12.5%
NVAXNOVAVAX INC$544.3M8.21%$181.31$9.74-94.6%
8.2%
VORXXXXVOR BIOPHARMA INC$479.3M7.23%β€”β€”
7.2%
AVIRATEA PHARMACEUTICALS INC$331.5M5.00%$61.75$4.98-91.9%
5.0%
FMTXFORMA THERAPEUTICS HLDGS INC$252.5M3.81%β€”β€”
3.8%
TGTXTG THERAPEUTICS INC$223.5M3.37%$48.20$53.31+10.6%
3.4%
NKTXNKARTA INC$184.4M2.78%$32.90$3.22-90.2%
2.8%
CCXICHEMOCENTRYX INC$182.3M2.75%β€”$19.10
2.8%
MGNXMACROGENICS INC$157.1M2.37%$31.85$4.71-85.2%
2.4%
ITOSITEOS THERAPEUTICS INC$151.0M2.28%β€”β€”
2.3%
IMGNIMMUNOGEN INC$149.2M2.25%β€”β€”
2.3%
TVTXTRAVERE THERAPEUTICS INC$140.2M2.11%$24.97$56.92+128.0%
2.1%
TILINSTIL BIO INC$122.2M1.84%$501.60$7.73-98.5%
1.8%
PHATPHATHOM PHARMACEUTICALS INC$117.0M1.76%$37.56$11.20-70.2%
1.8%
ETNB89BIO INC$112.2M1.69%β€”β€”
1.7%
KNTEKINNATE BIOPHARMA INC$112.0M1.69%β€”β€”
1.7%
RYTMRHYTHM PHARMACEUTICALS INC$103.6M1.56%$21.27$114.17+436.8%
1.6%
ZGNXZOGENIX INC$103.1M1.56%β€”β€”
1.6%
AXSMAXSOME THERAPEUTICS INC$93.7M1.41%$56.62$244.31+331.5%
1.4%
RCKTROCKET PHARMACEUTICALS INC COM$93.5M1.41%$44.37$3.84-91.3%
1.4%
ADVMADVERUM BIOTECHNOLOGIES INC$92.3M1.39%β€”β€”
1.4%
EWTXEDGEWISE THERAPEUTICS INC$84.9M1.28%$32.50$39.56+21.7%
1.3%
CRISCURIS INC$80.8M1.22%$226.40$6.93-96.9%
1.2%
BOLTBOLT BIOTHERAPEUTICS INC$78.3M1.18%$658.20$4.05-99.4%
1.2%
PCVXVAXCYTE INC$76.3M1.15%$19.75$58.39+195.7%
1.1%
MCRBSERES THERAPEUTICS INC$76.1M1.15%$411.80$7.74-98.1%
1.1%
SPRYSILVERBACK THERAPEUTICS INC$76.0M1.15%$43.63$8.56-80.4%
1.1%
IGMSIGM BIOSCIENCES INC$75.4M1.14%β€”β€”
1.1%
KALAKALA PHARMACEUTICALS INC$73.3M1.11%$16850.00$1.68-100.0%
1.1%
OLMAOLEMA PHARMACEUTICALS INC$71.3M1.08%$33.18$12.64-61.9%
1.1%

AttivitΓ  Trimestre su Trimestre

Q1 2021 vs. Q4 2020

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
VORXXXXVOR BIOPHARMA INC$479.3M
TILINSTIL BIO INC$122.2M-98.5%
EWTXEDGEWISE THERAPEUTICS INC$84.9M+21.7%
BOLTBOLT BIOTHERAPEUTICS INC$78.3M-99.4%
MCRBSERES THERAPEUTICS INC$76.1M-98.1%
DSGNDESIGN THERAPEUTICS INC$65.4M
CNTBXXXXCONNECT BIOPHARMA HLDGS LTD$55.3M
CTMXCYTOMX THERAPEUTICS INC$27.1M

Posizioni Chiuse (8)

TickerEmittenteNozionale
ARVNARVINAS INC$311.9M
KROSKEROS THERAPEUTICS INC$132.3M
FPRXFIVE PRIME THERAPEUTICS INC$72.9M
INBXINHIBRX INC$70.2M
LEGNLEGEND BIOTECH CORP$67.8M
CRDFCARDIFF ONCOLOGY INC$59.2M
PACBPACIFIC BIOSCIENCES OF CALIFORNIA INC$51.6M
ARQTARCUTIS BIOTHERAPEUTICS INC$32.8M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
CNCECONCERT PHARMACEUTICALS INC$-7.9M+66.4%
STSASATSUMA PHARMACEUTICALS INC$13.4M+26.3%
SLDBSOLID BIOSCIENCES INC$-7.2M+24.0%
TVTXTRAVERE THERAPEUTICS INC$16.0M+23.2%+128.0%
CNSTCONSTELLATION PHARMCETICLS INC$-1.0M+20.8%
RYTMRHYTHM PHARMACEUTICALS INC$-20.6M+16.6%+436.8%
MGNXMACROGENICS INC$57.1M+12.8%-85.2%
ASNDASCENDIS PHARMA A/S$-151.8M+9.3%+113.0%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
TGTXTG THERAPEUTICS INC$-228.4M-46.6%+10.6%
CCXICHEMOCENTRYX INC$-113.5M-25.5%
SCPHSCPHARMACEUTICALS INC$-0.5M-22.4%
NVAXNOVAVAX INC$121.8M-20.8%-94.6%
PHATPHATHOM PHARMACEUTICALS INC$-10.1M-18.6%-70.2%
CRISCURIS INC$17.7M-7.4%-96.9%
MISTMILESTONE PHARMACEUTICALS INC$-2.6M-3.5%
ARYAARYA SCIENCES ACQUISITION CO$2.5M-2.9%
← Torna agli Hedge Fund